Literature DB >> 18753864

Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

Didier K Ekouevi1, Patrick A Coffie, Renaud Becquet, Besigin Tonwe-Gold, Appolinaire Horo, Rodolphe Thiebaut, Valériane Leroy, Stéphane Blanche, François Dabis, Elaine J Abrams.   

Abstract

BACKGROUND: Pregnancy outcomes in women receiving highly active antiretroviral treatment (HAART) in Africa are not well described.
METHODS: HIV-1-infected pregnant women in the ANRS Ditrame Plus and the MTCT-Plus projects were included. Between March 2001 and July 2003, when HAART was not yet available, women eligible for HAART received a short-course antiretroviral regimen, zidovudine (ZDV) or (ZDV + lamivudine) and single dose of nevirapine for preventing mother-to-child transmission (PMTCT group). Between August 2003 and August 2007, eligible women for HAART received it (HAART group). The frequencies of low birth weight (LBW) (<2500 g), stillbirth and infant mortality are reported. Risk factors associated with LBW were investigated using a logistic regression model.
RESULTS: Of the 326 HIV-infected pregnant women, 175 women received short-course antiretroviral (median CD4 cell count 177 cells/microl) and 151 received HAART (median CD4 cell count 182 cells/microl). At 12 months, three paediatric infections (2.3%) occurred in the HAART group vs. 25 (16.1%) in the PMTCT group (P < 0.001). The rate of LBW was 22.3% in the HAART group and 12.4% in the PMTCT group (P = 0.02). In multivariable analysis (n = 309), after adjustment on maternal CD4 cell count, WHO stage, age and maternal BMI, HAART initiated before pregnancy [adjusted odds ratio (OR) 2.88, 95% confidence interval (CI) 1.10-7.51] and during pregnancy (adjusted OR 2.12, 95% CI 1.15-4.65) and maternal BMI at delivery (adjusted OR 2.43, 95% CI 1.20-4.91) were associated with LBW.
CONCLUSION: HAART in pregnant African women with advanced HIV disease substantially reduced mother-to-child transmission, but was associated with LBW.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753864     DOI: 10.1097/QAD.0b013e32830b8ab9

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  63 in total

1.  Maternal post-absorptive leucine kinetics during late pregnancy in US women with HIV taking antiretroviral therapy: a cross-sectional pilot study.

Authors:  W Todd Cade; Gautam K Singh; Mark R Holland; Dominic N Reeds; E Turner Overton; Nancy Cibulka; Karen Bahow; Rachel Presti; Andrea Stephens; Alison G Cahill
Journal:  Clin Nutr ESPEN       Date:  2015-08-01

2.  Predictors of CD4 eligibility for antiretroviral therapy initiation among HIV-infected pregnant women in Lusaka, Zambia.

Authors:  Katherine C Liu; Jessica Mulindwa; Mark J Giganti; Nande B Putta; Namwinga Chintu; Benjamin H Chi; Jeffrey S A Stringer; Elizabeth M Stringer
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-15       Impact factor: 3.731

3.  Multiple Overimputation to Address Missing Data and Measurement Error: Application to HIV Treatment During Pregnancy and Pregnancy Outcomes.

Authors:  Angela M Bengtson; Daniel Westreich; Patrick Musonda; Audrey Pettifor; Carla Chibwesha; Benjamin H Chi; Bellington Vwalika; Brian W Pence; Jeffrey S A Stringer; William C Miller
Journal:  Epidemiology       Date:  2016-09       Impact factor: 4.822

4.  Antiretrovirals in pregnancy: a note of caution.

Authors:  D Heather Watts; Lynne M Mofenson
Journal:  J Infect Dis       Date:  2012-10-12       Impact factor: 5.226

5.  The prevalence of stunting is high in HIV-1-exposed uninfected infants in Kenya.

Authors:  Christine J McGrath; Ruth Nduati; Barbra A Richardson; Alan R Kristal; Dorothy Mbori-Ngacha; Carey Farquhar; Grace C John-Stewart
Journal:  J Nutr       Date:  2012-02-29       Impact factor: 4.798

6.  Pregnancy outcomes and birth defects from an antiretroviral drug safety study of women in South Africa and Zambia.

Authors:  K Cherry Liu; Mansour Farahani; Tshililo Mashamba; Muthuhadini Mawela; Jessica Joseph; Nienke Van Schaik; Engela Honey; Michelle Gill; Waasila Jassat; Elizabeth M Stringer; Namiwnga Chintu; Richard G Marlink
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

7.  Repeat pregnancy in women with HIV infection in Latin America and the Caribbean.

Authors:  Regis Kreitchmann; Karen Megazzini; Victor Hugo Melo; Débora Fernandes Coelho; D Heather Watts; Margot Krauss; Maria Isabel Gouvea; Geraldo Duarte; Marcelo H Losso; George K Siberry
Journal:  AIDS Care       Date:  2015-08-19

8.  Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

Authors:  Jennifer Y Chen; Heather J Ribaudo; Sajini Souda; Natasha Parekh; Anthony Ogwu; Shahin Lockman; Kathleen Powis; Scott Dryden-Peterson; Tracy Creek; William Jimbo; Tebogo Madidimalo; Joseph Makhema; Max Essex; Roger L Shapiro
Journal:  J Infect Dis       Date:  2012-10-12       Impact factor: 5.226

Review 9.  Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions.

Authors:  Fernando C Barros; Zulfiqar Ahmed Bhutta; Maneesh Batra; Thomas N Hansen; Cesar G Victora; Craig E Rubens
Journal:  BMC Pregnancy Childbirth       Date:  2010-02-23       Impact factor: 3.007

10.  Effectiveness of multidrug antiretroviral regimens to prevent mother-to-child transmission of HIV-1 in routine public health services in Cameroon.

Authors:  Patrice Tchendjou; Chantal Same-Ekobo; Annie Nga; Mathurin Tejiokem; Anfumbom Kfutwah; Anne Njom Nlend; Landry Tsague; Anne Cécile Bissek; Daniel Ekoa; Joanna Orne-Gliemann; Dominique Rousset; Régis Pouillot; François Dabis
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.